Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5919694 | 1.00 | GPR84 (0.39) | GPR84FFAR1LMNAMEN1KMT2A | |
| SCHEMBL5919697 | 0.81 | KDM4E (0.52) | GPR84LMNAMEN1KMT2AKDM4E | |
| SCHEMBL415632 | 0.81 | KDM4E (0.52) | GPR84LMNAMEN1KMT2AKDM4E | |
| SCHEMBL28728247 | 0.81 | KDM4E (0.52) | GPR84LMNAMEN1KMT2AKDM4E | |
| SCHEMBL3306784 | 0.80 | MEN1 (0.40) | GPR84FFAR1LMNAMEN1KMT2A | |
| SCHEMBL28886965 | 0.80 | CYP4F2 (0.41) | GPR84FFAR1LMNAMEN1KMT2A | |
| SCHEMBL2119181 | 0.78 | NAAA (0.44) | LMNAMEN1KMT2ANAAAZDHHC7 | |
| SCHEMBL5665395 | 0.78 | NAAA (0.44) | LMNAMEN1KMT2ANAAAZDHHC7 | |
| SCHEMBL3190353 | 0.78 | NAAA (0.44) | LMNAMEN1KMT2ANAAAZDHHC7 | |
| SCHEMBL20531189 | 0.78 | NAAA (0.44) | LMNAMEN1KMT2ANAAAZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130210921-A1 | Method for Giving Warmth to Skin | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-08-15 | — | — | US | claimed |
| WO-2023152656-A2 | NOVEL HIGHLY SUSTAINABLE COMPOSITIONS FOR MODULATION OF GENE EXPRESSION IN HUMAN SKIN, AND METHODS OF PRODUCTION THEREOF | Visolis Technologies, Inc. (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20230248677-A1 | NOVEL HIGHLY SUSTAINABLE COMPOSITIONS FOR MODULATION OF GENE EXPRESSION IN HUMAN SKIN, AND METHODS OF PRODUCTION THEREOF | Visolis, Inc. | 2023-08-10 | — | — | US | disclosed |
| WO-2022260147-A1 | ADDITIVE FOR COSMETIC COMPOSITION | Ｓｐｉｂｅｒ株式会社 | 2022-12-15 | — | — | WO | disclosed |
| US-10874604-B2 | Cosmetic composition or external composition, and cosmetic raw material composition | DOW TORAY CO., LTD. (JP) | 2020-12-29 | — | — | US | disclosed |
| EP-2905319-B1 | SURFACE TREATMENT AGENT FOR POWDERS CONTAINING A CO-MODIFIED ORGANOPOLYSILOXANE AND COSMETIC COMPOSITIONS COMPRISING IT | DOW TORAY CO LTD (JP) | 2020-09-30 | — | — | EP | disclosed |
| US-20200038312-A1 | COSMETIC COMPOSITION OR EXTERNAL COMPOSITION, AND COSMETIC RAW MATERIAL COMPOSITION | DOW TORAY CO., LTD. (JP) | 2020-02-06 | — | — | US | disclosed |
| EP-3524228-A1 | COSMETIC COMPOSITION OR EXTERNAL COMPOSITION, AND COSMETIC RAW MATERIAL COMPOSITION | Dow Silicones Corporation (US) | 2019-08-14 | — | — | EP | disclosed |
| EP-2797992-B1 | DIGLYCERIN DERIVATE-MODIFIED SILICONE, EMULSIFIER FOR WATER-IN-OIL EMULSION USING THE SAME, EXTERNAL USE PREPARATION, AND COSMETIC COMPOSITION | DOW CORNING TORAY CO LTD (JP) | 2019-04-17 | — | — | EP | disclosed |
| US-10174170-B2 | Method for producing liquid high-purity polyhydric alcohol derivative-modified silicone or composition thereof | DOW CORNING TORAY CO., LTD. (JP) | 2019-01-08 | — | — | US | disclosed |
| WO-2013100207-A1 | NOVEL LIQUID ORGANOPOLYSILOXANE AND USES THEREOF | DOW CORNING TORAY CO., LTD. (JP) | 2013-07-04 | — | — | WO | disclosed |
| US-20110027326-A1 | External Composition for Skin | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2011-02-03 | — | — | US | disclosed |
| EP-2269652-A1 | COMPOSITION FOR EXTERNAL APPLICATION TO SKIN | Rohto Pharmaceutical Co., Ltd. (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-20080293673-A1 | N-ACETYGLUCOSAMINE DERIVATIVES AND USE THEREOF | KAO CORPORATION | 2008-11-27 | — | — | US | disclosed |
| US-7393937-B2 | N-acetylglucosamine derivatives and use thereof | KAO CORPORATION (JP) | 2008-07-01 | — | — | US | disclosed |
| US-20080118538-A1 | OIL DISPERSION OF POWDER BEING SURFACE-TREATED WITH SPECIFIC HALF ESTER OIL, AND COSMETIC COMPOSITION CONTAINING THE SAME | MIYOSHI KASEI, INC. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1881039-A1 | OIL DISPERSION OF POWDER BEING SURFACE-TREATED WITH SPECIFIC ACIDIC ESTER OIL, AND COSMETIC COMPOSITION CONTAINING THE SAME | Miyoshi Kasei, Inc. (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-20070265347-A1 | ENCAPSULATED OIL-IN-WATER TYPE EMULSION COMPOSITION | AJINOMOTO CO. INC (JP) | 2007-11-15 | — | — | US | disclosed |
| US-20060020127-A1 | N-acetylglucosamine derivatives and use thereof | KANEBO COSMETICS INC. (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1553101-A1 | N-ACETYLGLUCOSAMINE DERIVATIVES AND USE THEREOF | Kanebo Cosmetics Inc. (JP) | 2005-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020127-A1 | N-acetylglucosamine derivatives and use thereof | FUT6, B3GNT2, FUT5 | GPR84 979/4885FFAR1 696/4885LMNA 1583/4885 |
| US-20070265347-A1 | ENCAPSULATED OIL-IN-WATER TYPE EMULSION COMPOSITION | AGPAT2, GPR18, AGPAT5 | GPR84 6/4885FFAR1 50/4885LMNA 1946/4885 |
| US-10174170-B2 | Method for producing liquid high-purity polyhydric alcohol derivative-modified silicone or composition thereof | SAMM50, SORD, ADH1C | GPR84 4410/4885FFAR1 3914/4885LMNA 200/4885 |
| US-10874604-B2 | Cosmetic composition or external composition, and cosmetic raw material composition | H1-0, CUTA, HAO2 | GPR84 1179/4885FFAR1 145/4885LMNA 2298/4885 |
| US-20200038312-A1 | COSMETIC COMPOSITION OR EXTERNAL COMPOSITION, AND COSMETIC RAW MATERIAL COMPOSITION | H1-0, CUTA, HAO2 | GPR84 1179/4885FFAR1 145/4885LMNA 2298/4885 |
| US-20080293673-A1 | N-ACETYGLUCOSAMINE DERIVATIVES AND USE THEREOF | B3GNT2, FUT6, FUT5 | GPR84 1264/4885FFAR1 612/4885LMNA 1781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.